Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Systems, Sigma-Aldrich in Manufacturing and Distribution Deal

NEW YORK, May 4 – Proteome Systems of Sydney, Australia, and Sigma-Aldrich of St. Louis have entered a manufacturing and distribution collaboration, the companies said Friday. 

Under the agreement, the two companies will co-develop reagents and other products for proteomics research, which Sigma-Aldrich will manufacture and distribute. 

A Sigma-Aldrich spokesman said Proteome Systems would receive royalties on sales of products developed under the partnership and would also have the opportunity to receive a commission on products sold as part of its upcoming proteomics platform. 

Sigma-Aldrich recently released the first product to result from this agreement, its ProteoPrep line of sample preparation kits. ProteoPrep consists of three kits and two stand-alone reagents for use in proteomic research as well as standard research applications. 

A number of other products are currently under development as part of the partnership and Sigma-Aldrich expects them to be commercially available by June or July. 

Keith Williams, CEO of  Proteome  Systems, said that the products that result from the Sigma-Aldrich partnership would form part of  fully integrated  proteomics  platform, ProteomIQ, which Proteome Systems expects to launch in the third quarter of 2001. 

Sigma-Aldrich,  Proteome  Systems, and Shimadzu Biotech are members of The Proteomics Alliance, a group of companies collaborating on a systems approach to solving the complexities of the  proteome

Proteome Systems also has a partnership with Millipore to develop and market proteomics kits using Millipore’s sample preparation technology.

The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.